InflaRx N.V. (IFRX) vs Q32 Bio Inc. (QTTB)
A side-by-side comparison of InflaRx N.V. and Q32 Bio Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
IFRX
InflaRx N.V.
$1.59HealthcareDelayed quote: Oct 6, 2026, 2:45 PM EDT
QTTB
Q32 Bio Inc.
$8.15HealthcareDelayed quote: Oct 6, 2026, 2:45 PM EDT
Total return — IFRX vs QTTB
growth of $100 · dividends reinvested · last 9yIFRX -94.4% (-27.5%/yr)QTTB -97.5% (-33.7%/yr)IFRX compounded faster over this window
IFRX QTTB
IFRX vs QTTB: by the numbers
- •QTTB is the larger company ($243M vs $233M market cap).
- •QTTB is profitable (62.87% net margin) while IFRX runs a net loss (-155582.08%).
Metrics side by side
Valuation
| Metric | IFRX | QTTB |
|---|---|---|
| P/E ratio | N/A | 2.92 |
| P/S ratio | N/A | 4.51 |
| P/B ratio | 1.40 | 2.29 |
| EV / EBITDA | N/A | 6.46 |
Profitability
| Metric | IFRX | QTTB |
|---|---|---|
| Gross margin | -24677.94% | 99.84% |
| Operating margin | -164525.50% | 31.45% |
| Net margin | -155582.08% | 62.87% |
| ROE | -27.27% | 31.90% |
| ROIC | -25.38% | 19.43% |
Growth (annualized)
| Metric | IFRX | QTTB |
|---|---|---|
| Revenue CAGR (5Y) | N/A | 10.22% |
| Total return CAGR (5Y) | -7.34% | -41.51% |
Frequently asked
- Is IFRX or QTTB more profitable?
- QTTB runs the higher net margin — IFRX at -155582.08% versus QTTB at 62.87%.
- How have IFRX and QTTB total returns compared?
- Over the past 5 years, IFRX delivered -7.34% and QTTB delivered -41.51% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Q32 Bio P/E ratioInflaRx ROEQ32 Bio ROEInflaRx operating marginQ32 Bio operating marginInflaRx revenue growthQ32 Bio revenue growthInflaRx free cash flowQ32 Bio free cash flow
InflaRx & Q32 Bio appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.